T

Tempus AI Inc
NASDAQ:TEM

Watchlist Manager
Tempus AI Inc
NASDAQ:TEM
Watchlist
Price: 58.6 USD 11.66% Market Closed
Market Cap: 9.2B USD
Have any thoughts about
Tempus AI Inc?
Write Note

Tempus AI Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tempus AI Inc
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
T
Tempus AI Inc
NASDAQ:TEM
Cash from Investing Activities
-$40.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Investing Activities
-$6.2B
CAGR 3-Years
-17%
CAGR 5-Years
-27%
CAGR 10-Years
6%
Danaher Corp
NYSE:DHR
Cash from Investing Activities
-$7.3B
CAGR 3-Years
17%
CAGR 5-Years
-42%
CAGR 10-Years
-22%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Investing Activities
-$103.9m
CAGR 3-Years
28%
CAGR 5-Years
3%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Cash from Investing Activities
-$344m
CAGR 3-Years
22%
CAGR 5-Years
8%
CAGR 10-Years
-4%
IQVIA Holdings Inc
NYSE:IQV
Cash from Investing Activities
-$1.3B
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
-24%
No Stocks Found

Tempus AI Inc
Glance View

Market Cap
9B USD
Industry
Life Sciences Tools & Services

Tempus AI Inc. is revolutionizing the landscape of healthcare by leveraging cutting-edge artificial intelligence to enhance patient care and outcomes. Founded in 2015, the company has focused on integrating advanced data analytics and machine learning technologies to curate personalized treatment plans in oncology and beyond. Their innovative platform aggregates clinical and molecular data, allowing healthcare professionals to make informed decisions based on the latest research and patient-specific information. By partnering with leading healthcare institutions, Tempus is transforming the way physicians approach diagnosis and treatment, ultimately driving a more precise and effective healthcare system. For investors, Tempus represents a compelling opportunity in the rapidly growing health tech sector, especially as demands for personalized medicine continue to rise. The company's robust technology, combined with a strong leadership team and strategic partnerships, positions it as a frontrunner in data-driven healthcare solutions. Tempus has already demonstrated significant traction, evidenced by its expanding clientele and investment from prominent venture capital firms. With a commitment to enhancing patient outcomes and reducing healthcare costs, Tempus AI Inc. is not only shaping the future of medicine but also presenting a promising opportunity for those looking to invest in the intersection of technology and health.

TEM Intrinsic Value
47.39 USD
Overvaluation 19%
Intrinsic Value
Price
T

See Also

What is Tempus AI Inc's Cash from Investing Activities?
Cash from Investing Activities
-40.3m USD

Based on the financial report for Dec 31, 2023, Tempus AI Inc's Cash from Investing Activities amounts to -40.3m USD.

What is Tempus AI Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
30%

Over the last year, the Cash from Investing Activities growth was 30%.

Back to Top